| dc:title | High-Sensitivity C-Reactive Protein and Statin Initiation |
|---|
| dc:creator | Trpković, Andreja |
|---|
| dc:creator | Stanimirović, Julijana |
|---|
| dc:creator | Rizzo, Manfredi |
|---|
| dc:creator | Resanović, Ivana |
|---|
| dc:creator | S. Soskić, Sanja |
|---|
| dc:creator | Jevremović, Danimir |
|---|
| dc:creator | Isenović, Esma |
|---|
| dc:subject | high-sensitivity C-reactive protein |
|---|
| dc:subject | statin initiation |
|---|
| dc:subject | inflammation |
|---|
| dc:subject | cardiovascular risk prediction |
|---|
| dc:subject | atherosclerosis |
|---|
| dc:subject | cardiovascular disease |
|---|
| dc:subject | statin therapy |
|---|
| dc:subject | biomarkers |
|---|
| dc:description | The assessment of cardiovascular risk and treatment of cardiovascular diseases are major public health issues worldwide. Inflammation is now recognized as a key regulatory process that links multiple risk factors for atherosclerosis. The substantial number of patients having cardiovascular events lack commonly established risk factors. The utility of high-sensitivity C-reactive protein (hsCRP), a circulating biomarker related to inflammation, may provide additional information in risk prediction. This review will consider the impact of hsCRP level on initiation of statin therapy. |
|---|
| dc:publisher | SAGE Publishing |
|---|
| dc:date | 2015 |
|---|
| dc:type | info:eu-repo/semantics/article |
|---|
| dc:type | info:eu-repo/semantics/publishedVersion |
|---|
| dc:identifier | https://stomatoloskifakultet.rs/nauka/publikacija/990 |
|---|
| dc:identifier | DOI 10.1177/0003319714543000 |
|---|
| dc:identifier | ISSN 0003-3197 |
|---|
| dc:source | Angiology 66(6): 503-507 |
|---|
| dc:language | en |
|---|
| dc:rights | info:eu-repo/semantics/closedAccess |
|---|
| dc:rights | Sva prava zadržana |
|---|
